vs
Side-by-side financial comparison of Garden Stage Ltd (GSIW) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $704.3K, roughly 1.7× Garden Stage Ltd). Garden Stage Ltd runs the higher net margin — -464.9% vs -858.5%, a 393.6% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs 0.0%).
Virginia Stage Company (VSC) is a professional theater company located in Hampton Roads, Virginia. VSC presents locally produced plays for over 70,000 patrons a year both at the Wells Theatre in Norfolk, Virginia and throughout the community. A nonprofit theater, VSC has developed their "American Soil Series," a program that commissions plays of special regional interest, usually receiving their world premieres.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
GSIW vs LUCD — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $704.3K | $1.2M |
| Net Profit | $-3.3M | $-10.4M |
| Gross Margin | — | — |
| Operating Margin | — | -971.0% |
| Net Margin | -464.9% | -858.5% |
| Revenue YoY | 0.0% | 3.3% |
| Net Profit YoY | 0.0% | 16.0% |
| EPS (diluted) | — | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $704.3K | $1.2M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $828.0K | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $1.2M | $1.2M | ||
| Q2 24 | — | $976.0K | ||
| Q1 24 | — | $1.0M | ||
| Q4 23 | — | $1.0M |
| Q3 25 | $-3.3M | $-10.4M | ||
| Q2 25 | — | $-4.4M | ||
| Q1 25 | — | $-26.9M | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | $-3.3M | $-12.4M | ||
| Q2 24 | — | $-11.0M | ||
| Q1 24 | — | $-10.6M | ||
| Q4 23 | — | $-10.8M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 77.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | -971.0% | ||
| Q2 25 | — | -978.8% | ||
| Q1 25 | — | -1508.1% | ||
| Q4 24 | — | -1033.8% | ||
| Q3 24 | -277.9% | -997.8% | ||
| Q2 24 | — | -1146.7% | ||
| Q1 24 | — | -1078.1% | ||
| Q4 23 | — | -1101.3% |
| Q3 25 | -464.9% | -858.5% | ||
| Q2 25 | — | -381.7% | ||
| Q1 25 | — | -3249.8% | ||
| Q4 24 | — | -964.2% | ||
| Q3 24 | -277.5% | -1055.5% | ||
| Q2 24 | — | -1127.6% | ||
| Q1 24 | — | -1060.1% | ||
| Q4 23 | — | -1041.3% |
| Q3 25 | — | $-0.10 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | $0.21 | $-0.25 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.40 | ||
| Q4 23 | — | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.7M | $25.8M |
| Total Assets | $15.9M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $47.3M | ||
| Q2 25 | — | $31.1M | ||
| Q1 25 | — | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $24.9M | ||
| Q1 24 | — | $24.8M | ||
| Q4 23 | — | $18.9M |
| Q3 25 | $6.7M | $25.8M | ||
| Q2 25 | — | $7.9M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | $6.9M | $6.3M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $11.9M | ||
| Q4 23 | — | $-2.3M |
| Q3 25 | $15.9M | $53.2M | ||
| Q2 25 | — | $38.7M | ||
| Q1 25 | — | $32.8M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | $15.6M | $22.6M | ||
| Q2 24 | — | $34.1M | ||
| Q1 24 | — | $32.0M | ||
| Q4 23 | — | $27.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-809.6K | $-10.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-809.6K | $-10.9M | ||
| Q2 25 | — | $-10.5M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $-9.9M | ||
| Q3 24 | $-809.6K | $-10.2M | ||
| Q2 24 | — | $-11.5M | ||
| Q1 24 | — | $-12.6M | ||
| Q4 23 | — | $-10.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -87.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
